{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:41:58Z","timestamp":1759405318430,"version":"build-2065373602"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["R01HL155990"],"award-info":[{"award-number":["R01HL155990"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Immune checkpoint inhibitors (ICIs) are an essential class of immunotherapy drugs for cancer, but their impact on chronic inflammatory conditions remains unclear. Liver attenuation, a non-invasive measure of liver steatosis on CT, offers a way to assess liver inflammation. This study evaluates the impact of ICI therapy on liver attenuation and liver enzyme levels in cancer patients, building on prior research with a larger cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective cohort study of 164 cancer patients treated with ICIs at Vanderbilt University Medical Center between 2017 and 2022. Liver attenuation and enzyme levels (total bilirubin, AST, ALT, and alkaline phosphatase) were analyzed before and after \u22651 year of ICI therapy. Clinical factors such as weight change, liver metastasis, and steroid use were also assessed. Hepatic adverse events were characterized using CTCAE v5.0 criteria.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>No significant changes in liver attenuation were observed from baseline to post-treatment (59.86 \u00b1 8.07 HU vs 59.38 \u00b1 8.36 HU, p = 0.42). Liver enzyme levels also remained stable. Post-treatment liver abnormalities occurred in 23 patients (14.0%), with most being Grade 1 elevations (11.0%). Increased body weight was significantly associated with lower liver attenuation (p &amp;lt; 0.0001), and liver metastasis correlated with higher total bilirubin (p &amp;lt; 0.001) and AST levels (p &amp;lt; 0.01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>ICIs did not significantly change liver attenuation or enzyme levels, suggesting they may not exacerbate liver fat deposition or subclinical injury. Further research with additional imaging modalities is warranted.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1683982","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:04:52Z","timestamp":1759403092000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the impact of immune checkpoint inhibitors on liver steatosis and function: a retrospective cohort analysis"],"prefix":"10.3389","volume":"15","author":[{"given":"Sophie K.","family":"Schellhammer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica Quintos","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Planz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/imr.12531","article-title":"Introduction to checkpoint inhibitors and cancer immunotherapy","volume":"276","author":"Sharpe","year":"2017","journal-title":"Immunol Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-15-3266-5_23","article-title":"Therapeutic development of immune checkpoint inhibitors","volume":"1248","author":"Wang","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12916-015-0455-8","article-title":"Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis","volume":"13","author":"Bertrand","year":"2015","journal-title":"BMC Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00600-w","article-title":"Immune-checkpoint inhibitors: long-term implications of toxicity","volume":"19","author":"Johnson","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1077468","article-title":"Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives","volume":"13","author":"Liu","year":"2023","journal-title":"Front Pharmacol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.049981","article-title":"Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque","volume":"142","author":"Drobni","year":"2020","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31344","article-title":"Proatherogenic immune responses are regulated by the PD-1\/PD-L pathway in mice","volume":"117","author":"Gotsman","year":"2007","journal-title":"J Clin Invest"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.4368","article-title":"Ipilimumab therapy in patients with advanced melanoma and preexisting autoimmune disorders","volume":"2","author":"Johnson","year":"2016","journal-title":"JAMA Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05388-4","article-title":"Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes","volume":"611","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2023.100485","article-title":"From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease","volume":"65","author":"Rinella","year":"2023","journal-title":"J Lipid Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1186\/s12885-022-10090-9","article-title":"Immune checkpoint inhibitors and their impact on liver enzymes and attenuation","volume":"22","author":"Park","year":"2022","journal-title":"BMC Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.045","article-title":"Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study","volume":"63","author":"Mellinger","year":"2015","journal-title":"J Hepatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"15273","DOI":"10.1038\/s41598-018-33419-6","article-title":"Association between body mass index and fatty liver risk: A dose-response analysis","volume":"8","author":"Fan","year":"2018","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3969\/j.issn.2095-3941.2012.01.011","article-title":"Serological diagnosis of liver metastasis in patients with breast cancer","volume":"9","author":"Cao","year":"2012","journal-title":"Cancer Biol Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v16.i32.4084","article-title":"Serological diagnostic factors for liver metastasis in patients with colorectal cancer","volume":"16","author":"Wu","year":"2010","journal-title":"World J Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"HEP48","DOI":"10.2217\/hep-2023-0003","article-title":"The predictive value of liver tests for the presence of liver metastases","volume":"10","author":"Kimchy","year":"2023","journal-title":"Hepatic Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i32.5376","article-title":"Immune checkpoint inhibitor-related hepatotoxicity: A review","volume":"27","author":"Remash","year":"2021","journal-title":"World J Gastroenterol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000033659","article-title":"Low ALT, a marker of sarcopenia and frailty, is associated with shortened survival amongst myelodysplastic syndrome patients: A retrospective study","volume":"102","author":"Uliel","year":"2023","journal-title":"Med (Baltimore)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010174","article-title":"Low alanine aminotransferase as a marker for sarcopenia and frailty, is associated with decreased survival of bladder cancer patients and survivors\u2014A retrospective data analysis of 3075 patients","volume":"16","author":"Laufer","year":"2024","journal-title":"Cancers"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2019.1580169","article-title":"Circulating ALT levels in healthy volunteers over life-span: assessing aging paradox and nutritional implications","volume":"38","author":"Preuss","year":"2019","journal-title":"J Am Coll Nutr"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014254","article-title":"Alanine aminotransferase decreases with age: the rancho Bernardo study","volume":"5","author":"Dong","year":"2010","journal-title":"PLoS One"},{"key":"B22","first-page":"797","article-title":"Elevated serum liver enzymes in obesity: a dilemma during clinical trials","volume":"15","author":"Golik","year":"1991","journal-title":"Int J Obes"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(85)90012-5","article-title":"Characterization of elevated plasma alkaline phosphatase activity in genetically obese mice","volume":"34","author":"Menahan","year":"1985","journal-title":"Metabolism"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095286","article-title":"Grupul de Studiu al Scaderii Ponderale Involuntare. Cancer and Involuntary Weight Loss: Failure to Validate a Prediction Score","volume":"9","author":"Baicus","year":"2014","journal-title":"PLoS One"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1186\/s12885-025-14533-x","article-title":"Association between alkaline phosphatase and cancer in American adults: 2003\u20132016 NHANES","volume":"25","author":"Wu","year":"2025","journal-title":"BMC Cancer"},{"key":"B26","unstructured":"Alkaline phosphatase\n          \n          \n            \n              Lowe\n              D\n            \n            \n              Sanvictores\n              T\n            \n            \n              Zubair\n              M\n            \n            \n              John\n              S\n            \n          \n          Treasure Island (FL)\n          StatPearls Publishing\n          StatPearls\n          \n          2024"},{"key":"B27","article-title":"Alkaline phosphatase activity in blood group B or O secretors is fluctuated by the dinner intake of previous night","volume":"61","author":"Matsushita","year":"2013","journal-title":"Rinsho Byori"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1683982\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:04:56Z","timestamp":1759403096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1683982\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":27,"alternative-id":["10.3389\/fonc.2025.1683982"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1683982","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"article-number":"1683982"}}